Difference between revisions of "Rho(D) immune globulin (RhoGAM)"
(Created page with "==General information== Class/mechanism: Not entirely known. Rho(D) immune globulin forms anti-D-coated red blood cell complexes which are thought to bind to macrophage recept...") |
m |
||
| Line 1: | Line 1: | ||
==General information== | ==General information== | ||
Class/mechanism: Not entirely known. Rho(D) immune globulin forms anti-D-coated red blood cell complexes which are thought to bind to macrophage receptors in the spleen. This is then hypothesized to block the spleen's clearance of antibody-coated cells, which include platelets. Thus, the destruction of platelets in ITP is limited. | Class/mechanism: Not entirely known. Rho(D) immune globulin forms anti-D-coated red blood cell complexes which are thought to bind to macrophage receptors in the spleen. This is then hypothesized to block the spleen's clearance of antibody-coated cells, which include platelets. Thus, the destruction of platelets in ITP is limited. | ||
| − | |||
<br>Route: IV | <br>Route: IV | ||
<br>Extravasation: no information | <br>Extravasation: no information | ||
| Line 8: | Line 7: | ||
==Patient drug information== | ==Patient drug information== | ||
| − | *[http://www.uptodate.com/contents/rho-d-immune-globulin-patient-drug-information?source=search_result&search=rhogam&selectedTitle=3~56 Rho(D) immune globulin (RhoGAM) patient drug information (UpToDate)]<ref> | + | *[http://www.uptodate.com/contents/rho-d-immune-globulin-patient-drug-information?source=search_result&search=rhogam&selectedTitle=3~56 Rho(D) immune globulin (RhoGAM) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/rho-d-immune-globulin-patient-drug-information?source=search_result&search=rhogam&selectedTitle=3~56 Rho(D) immune globulin (RhoGAM) patient drug information (UpToDate)]</ref> |
==References== | ==References== | ||
Revision as of 13:34, 20 June 2014
General information
Class/mechanism: Not entirely known. Rho(D) immune globulin forms anti-D-coated red blood cell complexes which are thought to bind to macrophage receptors in the spleen. This is then hypothesized to block the spleen's clearance of antibody-coated cells, which include platelets. Thus, the destruction of platelets in ITP is limited.
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.